Karalius Mary C, Ramachandran Prashanth S, Wapniarski Annie, Wang Mary, Zia Maham, Hills Nancy K, Wintermark Max, Grose Charles, Dowling Michael M, Wilson Jenny L, Lee Sarah, Chung Melissa, Barry Megan, Xu Huichun, DeRisi Joseph L, Wilson Michael R, Fullerton Heather J
Department of Neurology, Weill Institute for Neurosciences (M.C.K., P.S.R., A.W., M. Wang, M.Z., N.K.H., M.R.W., H.J.F.), University of California San Francisco.
Department of Pediatrics (M.C.K., H.J.F.), University of California San Francisco.
Stroke. 2025 Aug;56(8):2110-2121. doi: 10.1161/STROKEAHA.124.050548. Epub 2025 May 1.
Acute respiratory infection transiently increases risk for childhood arterial ischemic stroke (AIS). We hypothesize that this paradox of a common exposure linked to a rare outcome could be explained by either (1) the infection hypothesis: unusual or multiple pathogens or (2) the host response hypothesis: heterogeneity in the inflammatory response to infection. We leverage metagenomic next-generation sequencing (mNGS), a comprehensive microbial detection tool, to test the first hypothesis.
The VIPS II study (Vascular Effects of Infection in Pediatric Stroke II) prospectively enrolled children with AIS at 22 international sites over 5 years (December 2016 to January 2022). Sites measured prestroke clinical infection via standardized parental interviews and chart abstraction. To assess more broadly the background spectrum of pathogens, a central research laboratory performed mNGS on plasma and oropharyngeal swabs collected within 72 hours of stroke. mNGS was also performed on biological samples from stroke-free children (June 2017 to January 2022), both without (well) and with (ill) documentation of clinical infection.
VIPS II enrolled 205 patients with AIS, 95 stroke-free well children, and 47 stroke-free ill children. Clinical infection, most commonly upper respiratory tract infection, was detected in 81 of 205 (40%) of patients. Both plasma and oropharyngeal swab mNGS data were available for 190 of 205 patients with AIS, 91 of 95 stroke-free well children, and 27 of 47 stroke-free ill children. mNGS detected viruses in 27 of 190 (14%) patients with AIS, 9 of 91 stroke-free well children (10%), and 9 of 27 (33%) stroke-free ill children. Most were common upper respiratory viruses. Coinfections were rare. Similar viruses were found in patients with AIS and stroke-free children.
mNGS detected a variety of common childhood viruses in both patients with AIS and stroke-free children, suggesting that the type of infection does not explain AIS susceptibility. Rather, the alternative hypothesis regarding an unusual host immune response to common infections in the pathogenicity of AIS should be further explored.
急性呼吸道感染会短暂增加儿童动脉缺血性卒中(AIS)的风险。我们推测,这种常见暴露与罕见结局之间的矛盾现象可能由以下两种情况之一解释:(1)感染假说:不寻常或多种病原体;(2)宿主反应假说:对感染的炎症反应存在异质性。我们利用宏基因组下一代测序(mNGS)这一全面的微生物检测工具来检验第一个假说。
VIPS II研究(小儿卒中感染的血管效应II)在5年时间里(2016年12月至2022年1月)在22个国际地点前瞻性纳入了AIS患儿。各研究地点通过标准化的家长访谈和病历摘要来测量卒中前的临床感染情况。为了更广泛地评估病原体的背景谱,一个中央研究实验室对卒中后72小时内采集的血浆和口咽拭子进行了mNGS检测。还对无卒中儿童(2017年6月至2022年1月)的生物样本进行了mNGS检测,这些儿童既有未记录临床感染情况的(健康儿童),也有记录了临床感染情况的(患病儿童)。
VIPS II研究纳入了205例AIS患者、95例无卒中的健康儿童和47例无卒中的患病儿童。在205例患者中有81例(40%)检测到临床感染,最常见的是上呼吸道感染。205例AIS患者中有190例、95例无卒中的健康儿童中有91例以及47例无卒中的患病儿童中有27例同时获得了血浆和口咽拭子的mNGS数据。mNGS在190例AIS患者中有27例(14%)检测到病毒,在91例无卒中的健康儿童中有9例(10%)检测到病毒,在27例无卒中的患病儿童中有9例(33%)检测到病毒。大多数是常见的上呼吸道病毒。合并感染很少见。在AIS患者和无卒中儿童中发现了相似的病毒。
mNGS在AIS患者和无卒中儿童中均检测到多种常见的儿童病毒,这表明感染类型并不能解释AIS的易感性。相反,关于AIS发病机制中宿主对常见感染的异常免疫反应这一替代假说应进一步探索。